ORANGE COUNTY EARNINGS
PharmaPrint Inc.: The Irvine developer and manufacturer of dietary supplements and pharmaceuticals derived from plant extracts posted net income of $2.7 million, or 18 cents a share, for the third fiscal quarter, contrasted with a net loss of $4.3 million, or 39 cents a share, for the like period a year ago. Revenue for the quarter ended Dec. 31 reached a record $11.9 million, which included $7.5 million in nonrecurring licensing and development fees. No revenue was recorded for the year-earlier period.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.